Mary Kay Ladone

Mary Kay Ladone

DirectoratBioventus· In proxies 2024–2025

Mary Kay Ladone sits on 3 public boards.

Boards1

  • BioventusDirector · 4 yr on the boardIndependentAudit and Risk, Compensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. BioventusPublic company · 2 yr
    • Director2024 – Present · 2 yrStock in role +177%
  2. Novanta Inc.Public company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  3. Kestra Medical Technologies, Inc.Public company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?